Shell Asset Management Co. Sells 2,401 Shares of Oscar Health, Inc. (NYSE:OSCR)



Shell Asset Management Co. cut its holdings in Oscar Health, Inc. (NYSE:OSCR – Get Rating) by 13.5% in the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 15,343 shares of the company’s stock after selling 2,401 shares during the period. Shell Asset Management Co.’s holdings in Oscar Health were worth $153,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds also recently bought and sold shares of OSCR. Southeastern Asset Management Inc. TN bought a new position in Oscar Health in the 4th quarter worth approximately $71,512,000. Lakestar Growth I GP Ltd bought a new position in Oscar Health in the 4th quarter worth approximately $18,086,000. Industry Ventures LLC bought a new position in Oscar Health in the 4th quarter valued at $16,541,000. Mitsubishi UFJ Trust & Banking Corp boosted its holdings in Oscar Health by 118.8% in the 4th quarter. Mitsubishi UFJ Trust & Banking Corp now owns 1,179,420 shares of the company’s stock valued at $9,258,000 after purchasing an additional 640,320 shares during the period. Finally, Cubist Systematic Strategies LLC boosted its holdings in Oscar Health by 465.3% in the 4th quarter. Cubist Systematic Strategies LLC now owns 380,116 shares of the company’s stock valued at $2,984,000 after purchasing an additional 312,878 shares during the period. 98.65% of the stock is owned by institutional investors.

Insider Activity

In other news, EVP Alessandrea C. Quane sold 11,300 shares of Oscar Health stock in a transaction dated Monday, June 6th. The shares were sold at an average price of $5.01, for a total transaction of $56,613.00. Following the sale, the executive vice president now owns 131,018 shares of the company’s stock, valued at approximately $656,400.18. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. In other news, EVP Alessandrea C. Quane sold 11,300 shares of Oscar Health stock in a transaction dated Monday, June 6th. The shares were sold at an average price of $5.01, for a total transaction of $56,613.00. Following the sale, the executive vice president now owns 131,018 shares of the company’s stock, valued at approximately $656,400.18. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, CFO Richard Scott Blackley sold 19,546 shares of Oscar Health stock in a transaction dated Monday, June 6th. The shares were sold at an average price of $5.01, for a total transaction of $97,925.46. Following the sale, the chief financial officer now directly owns 264,307 shares in the company, valued at approximately $1,324,178.07. The disclosure for this sale can be found here.

Oscar Health Price Performance

OSCR stock opened at $6.24 on Monday. The firm’s 50-day moving average price is $4.88 and its two-hundred day moving average price is $6.55. Oscar Health, Inc. has a 12-month low of $3.89 and a 12-month high of $18.89. The stock has a market capitalization of $1.32 billion, a price-to-earnings ratio of -2.33 and a beta of 1.32. The company has a current ratio of 1.20, a quick ratio of 1.20 and a debt-to-equity ratio of 0.22.

Oscar Health (NYSE:OSCR – Get Rating) last released its quarterly earnings data on Tuesday, May 10th. The company reported ($0.36) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.40) by $0.04. Oscar Health had a negative net margin of 22.93% and a negative return on equity of 37.23%. The firm had revenue of $972.77 million for the quarter, compared to analysts’ expectations of $803.04 million. During the same quarter in the previous year, the company earned ($0.98) earnings per share. As a group, equities analysts predict that Oscar Health, Inc. will post -2.58 earnings per share for the current year.

Wall Street Analyst Weigh In

OSCR has been the subject of a number of research analyst reports. Morgan Stanley dropped their price objective on shares of Oscar Health from $18.00 to $12.00 and set an “overweight” rating for the company in a report on Thursday, June 9th. Bank of America downgraded shares of Oscar Health from a “neutral” rating to an “underperform” rating and dropped their price objective for the stock from $6.00 to $4.50 in a report on Wednesday, June 15th. Two equities research analysts have rated the stock with a sell rating, two have given a hold rating and two have issued a buy rating to the company’s stock. According to data from MarketBeat.com, Oscar Health currently has an average rating of “Hold” and a consensus price target of $9.50.

About Oscar Health

(GetRated)

Oscar Health, Inc provides health insurance products and services in the United States. The company offers Individual & Family, Small Group, and Medicare Advantage plans, as well as +Oscar, a technology driven platform designed to help providers and payor clients to engage with members and patients.

Further Reading

Want to see what other hedge funds are holding OSCR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Oscar Health, Inc. (NYSE:OSCR – Get Rating).

Institutional Ownership by Quarter for Oscar Health (NYSE:OSCR)



Receive News & Ratings for Oscar Health Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Oscar Health and related companies with MarketBeat.com’s FREE daily email newsletter.

.

Leave a Comment